Glenmark Life Sciences Ltd - 543322 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 48111 Name of the Signatory :- Rudalf CorrieaDesignation :- Company Secretary and Compliance Officer20-01-2022